Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[1997, a good year for telomerase?]

E Gilson1

  • 1Laboratoire de biologie moléculaire et cellulaire, UMR49, Centre national de la recherche scientifique, Ecole normale supérieure de Lyon, France.

Bulletin Du Cancer
|September 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learning from each other: Cross-cutting diagnostic development activities between magnetic and inertial confinement fusion (invited).

The Review of scientific instruments·2024
Same author

PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy.

Oncogene·2010
Same author

Aberrant telomere structure is characteristic of resistant chronic lymphocytic leukaemia cells.

Leukemia·2009
Same author

Large telomerase RNA, telomere length heterogeneity and escape from senescence in Candida glabrata.

FEBS letters·2009
Same author

A haploid-specific transcriptional response to irradiation in Saccharomyces cerevisiae.

Nucleic acids research·2005
Same author

TRF2 inhibition promotes anchorage-independent growth of telomerase-positive human fibroblasts.

Oncogene·2005
Same journal

[ONCONNECTE À L'EMPLOI, feedback after three years of a program to prepare for returning to work after cancer in Franche-Comté].

Bulletin du cancer·2026
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
See all related articles

In 1997, researchers discovered the human telomerase catalytic subunit resembles reverse transcriptases. Studies showed telomerase is vital for germ cell telomere length but not essential for tumor development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Context:

  • Telomere length maintenance is crucial for cellular aging and cancer.
  • Understanding telomerase function is key to comprehending cell proliferation control and oncogenesis.

Purpose:

  • To elucidate the role of telomerase in cell proliferation and cancer.
  • To investigate the essentiality of telomerase for tumor formation.

Summary:

  • The catalytic subunit of human telomerase shares significant homology with reverse transcriptases.
  • Mice lacking the RNA component of telomerase maintained telomere length in germ cells, indicating its essential role in this process.
  • These mice did not exhibit an increased predisposition to tumor formation, suggesting telomerase is not strictly required for oncogenesis.

Related Experiment Videos

Impact:

  • This research advanced the understanding of telomerase as a reverse transcriptase.
  • It provided critical insights into the non-essential role of telomerase in tumor initiation, challenging previous hypotheses.